UNA-NY Announces 2017 Honorees for UN Day Humanitarian of the Year Award:

Mr. Joseph R. Biden Jr., 47th Vice President of the U.S., and Mr. Youngsuk Chi, Chairman of Elsevier

 

 

 

2017 Gala Dinner Event Celebrates Elsevier's Commitment
to Global Health and Partnerships, Information Analytics, and
the Cancer Moonshot Initiative

New York, November 3, 2017 | The United Nations Association of New York (UNA-NY) announced the honorees of the annual United Nations Day Humanitarian of the Year Award today.

The Award is given to individuals or organizations for their unique contributions to, and exemplary support of the ideals and work of the UN. Vice President Joe Biden is being honored for "extraordinary commitment and tireless dedication to leading global health initiatives to improve cancer outcomes," and Mr. Chi for his "extraordinary commitment and tireless dedication to improving global health and information analytics."

"Every day, every minute matters to patients and we must bring that sense of urgency to our cancer research and care systems," said Vice President Joe Biden.

"We are in the midst of a technological revolution that is providing new insights into human biology and cancer. In this era of big data, we are amassing large amounts of information that is transforming how we approach cancer treatment and prevention," said Elsevier Chairman Chi. "I'm grateful that the UN Association of New York is celebrating this revolution, and I'm proud to receive this honor on behalf of the work Elsevier is doing to accelerate progress towards improved global health."

"In Mr. Biden and Elsevier, this year's honorees exemplify the type of personal leadership and private sector commitment vital to helping the United Nations achieve its goals," said Abid Qureshi, President of UNA-NY.

The Awards will be given at an exclusive national gathering this evening that brings together policymakers, diplomats, United Nations supporters, business leaders, and celebrities to call attention to the vital role the UN plays in helping the global community advance peace, prosperity and justice and to honor individuals and corporations for their global leadership in advancing UN causes.

The Lancet Oncology Commission on Future Cancer Research Priorities

Under Vice President Biden's leadership, the White House Cancer Moonshot resulted in new programs and collaborations to improve cancer research and care. Additionally, the Cancer Moonshot was included in the 21st Century Cures Act signed into law in December 2016 in the USA, providing nearly US$2 billion of funding for cancer research and precision medicine.

This week, Elsevier's leading oncological research journal, The Lancet Oncology, published a special issue on and hosted a symposium for its Commission on Future Cancer Research Priorities in the USA. The report finds that a fundamental shift in how cancer research is conducted and how cancer care is delivered in the USA is required in order to deliver on the US Cancer Moonshot initiative. The Commission was launched on November 1st at an event on Capitol Hill, Washington, DC.

The Commission report sets out a detailed roadmap to deliver on the Cancer Moonshot's Blue Ribbon Panel recommendations, including a focus on prevention, a new model for drug discovery and development, a vast expansion of patient access to clinical trials, and an emphasis on targeted interventions to improve cancer care for underserved groups, specifically children, cancer survivors and minority groups. The report emphasizes the importance of addressing health disparities in all recommendations.

The Lancet Oncology Commission recommends multiple priority areas for research in the USA that would substantially accelerate progress towards improved cancer control. Further, the Commission's conclusions should help facilitate new international collaborations given the degree of interdependency that exists between nations.

 

About Elsevier

Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

Tom Reller
VP, Communications
T.reller@elsevier.com